載入...
Mass Balance Study of the Engineered Cationic Antimicrobial Peptide, WLBU2, Following a Single Intravenous Dose of 14C-WLBU2 in Mice
BACKGROUND: To address multidrug resistance, we developed engineered cationic antimicrobial peptides (eCAPs). Lead eCAP WLBU2 displays potent activity against drug-resistant bacteria and effectively treats lethal bacterial infections in mice, reducing bacterial loads to undetectable levels in divers...
Na minha lista:
| 發表在: | Curr Rev Clin Exp Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8083974/ https://ncbi.nlm.nih.gov/pubmed/32778037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1574884715666200810094201 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|